6550--Notice of Intent to Sole-Source T-SPOT. TB® Reagents and Kits

Closed Special Notice Posted

Solicitation number
36C24227Q0036
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs, Veterans Integrated Service Network 2, through its Network Contracting Office 2, issued a notice of intent on October 2, 2026 to award a sole-source, firm-fixed-price contract to Euroimmun US Incorporated for T-SPOT.TB reagents and associated kits, with responses due by 4:00 PM EST on October 16, 2026. Oxford Immunotec manufactures the reagents; Euroimmun US Incorporated is the sole authorized U.S. distributor and the only supplier legally authorized to provide FDA-approved reagents meeting FDA, CLIA, CAP, and Joint Commission requirements. The T-SPOT.TB assay is a patented IGRA platform with proprietary antigen panels, controls, and AIM-V media cleared exclusively for use with the original equipment manufacturer's platform. The reagents are required for tuberculosis testing at VA Western New York Healthcare System's Buffalo VA Medical Center.

Though this is not a competitive solicitation, interested parties may submit a one-page capability statement including company name, UEI number, socioeconomic status, and proof of authorization to provide OEM reagents. The Government reserves discretion to conduct a competitive procurement in the future based on information received. Prospective contractors must be registered in SAM.gov to be eligible for award. The contract is structured as a Blanket Purchase Agreement with a base year plus four option years running through October 31, 2031. PSC code is 6550; NAICS code is 334516.

Notice text

This notice is being published in accordance with Revolutionary FAR Overhaul Federal Acquisition Regulation (RFO FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions.

The Department of Veterans Affairs, Network Contracting Office (NCO) 2, hereby provides notice of its intent to award a sole source, firm fixed price contract to Euroimmun US Incorporated, the sole authorized U.S. distributor of T SPOT.TB® reagents and associated kits manufactured by Oxford Immunotec. These reagents are required for tuberculosis testing at VA Western New York Healthcare System (VAWNYHS) Buffalo VA Medical Center (VAMC).

This determination is made in accordance with RFO FAR 12.201-1, Only one responsible source and no other supplies or services will satisfy agency requirements.

The T SPOT.TB® assay is a patented IGRA platform, and its reagents including the antigen panels, controls, and AIM V media are proprietary and FDA cleared only for use with the OEM platform. Oxford Immunotec holds the exclusive patent rights, and Euroimmun US Incorporated is the only supplier legally authorized to provide these FDA approved reagents for federal healthcare facilities. No other vendor can supply reagents that meet FDA, CLIA, CAP, and Joint Commission requirements.

This notice is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to this requirement by submitting a:

Capability Statement (1 page maximum)

Company Name

UEI Number

Socioeconomic Status

Proof of authorization to provide the OEM reagents

Responses must be received no later than 4:00 PM EST on October 16, 2026 to Myra.Green2@va.gov

A determination not to compete this proposed action is solely within the discretion of the Government. Information received will only be considered for determining whether to conduct a competitive procurement in the future.

Prospective contractors must be registered in SAM.gov to be eligible for award.

Files

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors